This was the stock's third consecutive day of gains.

As Bird Flu Outbreak Worsens, Zoetis Gets Green Light for Poultry Vaccine By India Edwards HealthDay Reporter TUESDAY, Feb.

Greenwich Academy's 2025 commencement speaker is Kristin Coveny Peck, the CEO of Zoetis, an animal health company.

Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find ...

Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...

Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments ...

Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...

The U.S. Department of Agriculture has given a conditional approval to Zoetis to use its bird flu vaccine in poultry, the ...

Q4 2024 Earnings Call Feb 13, 2025, 8:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants.

Phibro Animal Health projects strong 2025 revenue growth despite debt concerns. Read this artile to know why I think PAHC ...

Zoetis has been granted a conditional license from the USDA for its avian flu vaccine. Since February 2022, more than 150 ...

Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting ...